Oncotype DX in clinical practice: impact on treatment decisions and healthcare system economy
Oncotype DX results in lower rates of chemotherapy prescription and in possible healthcare cost savings.
Authors
- Marco Maria Germani (ORCID: https://orcid.org/0000-0002-1036-5869)
- Silvia Maria Rossi
- Giuseppe Perrone (ORCID: https://orcid.org/0000-0002-9538-5729)
- G Gullotta
- Giovanna Sabarese (ORCID: https://orcid.org/0000-0002-6841-1610)
- Angelo Capozzi
- Stefania Sfregola
Institutions
- Università Campus Bio-Medico (IT)
- Campus Bio Medico University Hospital (IT)
Publication Details
- Journal
- Pathologica
- Published
- 2025-10-01
- DOI
- https://doi.org/10.32074/1591-951x-n1139
- Primary Topic
- Economic and Financial Impacts of Cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00